Demestre, M., Herzberg, J., Holtkamp, N., Hagel, C., Reuss, D., Friedrich, R. E., . . . Kurtz, A. (2010). Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model. Journal of neuro-oncology, 98(1), .
Chicago Style (17th ed.) CitationDemestre, Maria, et al. "Imatinib Mesylate (Glivec) Inhibits Schwann Cell Viability and Reduces the Size of Human Plexiform Neurofibroma in a Xenograft Model." Journal of Neuro-oncology 98, no. 1 (2010).
MLA (9th ed.) CitationDemestre, Maria, et al. "Imatinib Mesylate (Glivec) Inhibits Schwann Cell Viability and Reduces the Size of Human Plexiform Neurofibroma in a Xenograft Model." Journal of Neuro-oncology, vol. 98, no. 1, 2010.
Warning: These citations may not always be 100% accurate.